Applicable to second-line treatment drugs for pulmonary tuberculosis who have failed treatment with first-line anti-tuberculosis drugs (such as streptomycin, isoniazid, rifampicin and ethambutol), or have toxic effects on one or more of the above drugs Or when the bacteria are resistant, this product can be used as one of the combination drugs.

Market Analysis and Insights: Global Capastat Sulfate Market
The global Capastat Sulfate market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Capastat Sulfate Scope and Market Size
The global Capastat Sulfate market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Capastat Sulfate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
White Powder
Off-White Powder

Segment by Application
Pharmaceutical intermediates
Chemical Intermediate
Others

The Capastat Sulfate market is analysed and market size information is provided by regions (countries). Segment by Application, the Capastat Sulfate market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Cayman
Boc Sciences
Muse Chem
Target Mol
Merck
Paragos
Sino Reagent
HX-R
Fortuna Chem
9Ding Chem